Gastrointestinal Cancer News

Survivors of most types of cancers demonstrated increased medium- to long-term risk for at least one cardiovascular disease compared with the general population, according to results of a retrospective study published in The Lancet.

The combination of adavosertib, gemcitabine and radiation appeared safe and potentially effective for patients with newly diagnosed, locally advanced pancreatic cancer, according to results of a phase 1 dose-escalation study published in Journal of Clinical Oncology.

Patients with metastatic colorectal cancer who exercised regularly achieved longer PFS than those who did not, according to results of a companion study to the Cancer and Leukemia Group B/SWOG 80305 trial published in Journal of Clinical Oncology.

The FDA today granted accelerated approval to entrectinib for the treatment of adults and children with cancers that harbor neurotrophic tyrosine receptor kinase, or NTRK, gene fusion and for whom there are no effective treatments.

A low-cost, literacy-appropriate intervention with follow-up phone calls if needed increased colorectal cancer screening among an underserved, rural population in Louisiana, according to results of a two-arm randomized trial published in Cancer.

Sita Kugel, PhD, a scientist at Fred Hutchinson Cancer Research Center, received an NCI award that will fund her laboratory’s research into an aggressive form of pancreatic cancer.

Cell-free DNA fragmentation profiles could be used for screening, early detection and monitoring of certain cancer types, study findings suggest.

Individuals aged 85 years and older underwent cancer screening at “unexpectedly high” rates even though it is generally not recommended for this age group, according to a report published in CA: A Cancer Journal for Clinicians.

The U.S. Preventive Services Task Force reaffirmed its stance against pancreatic cancer screening for asymptomatic adults with no family history of the disease.

Data presented at this year’s American Association for Cancer Research Annual Meeting suggest young-onset colorectal cancer often is misdiagnosed and identified at later stages.